Oracle Investment Management as of Sept. 30, 2020
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 16 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 58.8 | $444M | 2.0M | 219.38 | |
| Biohaven Pharmaceutical Holding | 18.5 | $139M | 2.1M | 65.01 | |
| Opko Health (OPK) | 6.5 | $49M | 13M | 3.69 | |
| Accelr8 Technology | 5.8 | $44M | 4.1M | 10.66 | |
| Aspira Womens Health | 3.5 | $27M | 8.6M | 3.08 | |
| Pacific Biosciences of California (PACB) | 2.3 | $17M | 1.7M | 9.87 | |
| Soleno Therapeutics Com New | 1.2 | $9.2M | 3.7M | 2.51 | |
| BioCryst Pharmaceuticals (BCRX) | 1.2 | $8.7M | 2.5M | 3.43 | |
| Agenus Com New Call Option (AGEN) | 0.7 | $4.9M | 13M | 0.37 | |
| Antares Pharma | 0.6 | $4.6M | 1.7M | 2.70 | |
| Motus Gi Hldgs Incorporated | 0.5 | $3.7M | 3.8M | 0.98 | |
| Biogen Idec (BIIB) | 0.1 | $1.0M | 3.7k | 283.62 | |
| Y Mabs Therapeutics (YMAB) | 0.1 | $968k | 25k | 38.39 | |
| Contrafect Corp Com New | 0.1 | $885k | 168k | 5.28 | |
| Biolase Com New | 0.1 | $478k | 1.7M | 0.27 | |
| Amarin Corp Spons Adr New Call Option (AMRN) | 0.0 | $35k | 1.3M | 0.03 |
